Germany's LION Bioscience has released SRS everEST, its new completetranscript reconstruction software, which the company expects to be of "great use in the discovery and analysis of genes."
The company says the new module will complement its Life Science Informatics platform as the basis for its i-biology solution, which is being developed to re-engineer and shorten the life science industry's product development cycle.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze